Cardio Diagnostics Holdings reported revenue of $0.01M and net income of -$1.50M for the quarter ended Jun 2026, down 28.3% year over year. This income statement covers 20 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||
| Revenue | 950.00 | 0.00M | 0.01M | 0.01M | 0.02M | 0.01M | 0.01M | 0.00M | 940.00 | 0.01M | 0.00M | 0.00M | 0.00M | 0.01M | ||||||
| Operating items | ||||||||||||||||||||
| Research & DevelopmentR&D | 0.00M | 0.01M | 0.00M | 0.03M | 0.09M | 0.01M | 0.04M | 0.01M | 0.01M | 0.01M | 0.01M | 0.20M | 0.12M | 0.18M | 0.13M | 0.16M | ||||
| Selling, General & AdministrativeSG&A | 0.21M | 0.75M | 1.13M | 2.32M | 1.56M | 2.51M | 1.38M | 1.49M | 4.12M | 1.29M | 1.42M | 0.04M | 1.28M | 1.30M | 1.71M | -0.01M | 1.46M | 1.14M | ||
| Restructuring CostsRestructuring | 0.06M | 0.06M | ||||||||||||||||||
| Other Operating ExpensesOther Opex | 721.00 | -0.03M | -0.02M | 0.02M | 0.03M | 0.05M | 0.04M | 0.04M | 0.05M | 0.04M | -0.01M | -0.01M | 1.28M | 0.23M | 0.21M | 1.47M | 0.20M | 0.20M | ||
| Operating ExpensesOpex | 721.00 | 0.23M | 0.79M | 1.15M | 2.38M | 1.70M | 2.55M | 1.45M | 1.55M | 4.17M | 1.29M | 1.42M | 1.52M | 1.63M | 1.69M | 1.71M | 1.47M | 1.79M | 1.50M | |
| Operating IncomeOp. Inc | -721.00 | -0.23M | -0.79M | -1.15M | -2.38M | -1.70M | -2.55M | -1.44M | -1.54M | -4.16M | -1.28M | -1.41M | -1.52M | -1.63M | -1.68M | -1.71M | -1.46M | -1.78M | -1.50M | |
| EBIT | -721.00 | -0.23M | -0.79M | -1.15M | -2.38M | -1.70M | -2.55M | -1.44M | -1.54M | -4.16M | -1.28M | -1.41M | -1.52M | -1.63M | -1.68M | -1.71M | -1.46M | -1.78M | -1.50M | |
| Non-operating items | ||||||||||||||||||||
| Non Operating Interest Expenses | 5.02M | 1.05M | 0.57M | 0.10M | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | ||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | 0.00M | 0.01M | 0.37M | |||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.06M | -0.06M | 5.69M | -1.47M | -0.49M | -0.20M | -0.01M | -0.01M | -0.00M | -0.00M | -0.00M | -0.00M | -0.00M | -0.00M | -0.00M | -0.00M | ||||
| Net income details | ||||||||||||||||||||
| EBT | -721.00 | -0.29M | -0.84M | -1.15M | -2.38M | -1.03M | -4.02M | -1.93M | -1.39M | -4.16M | -1.29M | -1.41M | -1.52M | -1.64M | -1.68M | -1.71M | -1.47M | -1.79M | -1.50M | |
| Profit After TaxPAT | -721.00 | -0.29M | -0.84M | -1.15M | -2.38M | -1.03M | -4.02M | -1.93M | -1.39M | -4.16M | -1.29M | -1.41M | -1.52M | -1.64M | -1.68M | -1.71M | -1.47M | -1.79M | -1.50M | |
| Income from Continuing OperationsIncome (Continuing) | -721.00 | -0.29M | -0.84M | -1.15M | -2.38M | -1.03M | -4.02M | -1.93M | -1.39M | -4.16M | -1.29M | -1.41M | -1.52M | -1.64M | -1.68M | -1.71M | -1.47M | -1.79M | -1.50M | |
| Consolidated Net IncomeConsol Net Inc. | -721.00 | -0.29M | -0.84M | -1.15M | -2.38M | -1.03M | -4.02M | -1.93M | -1.39M | -4.16M | -1.29M | -1.41M | -1.52M | -1.64M | -1.68M | -1.71M | -1.47M | -1.79M | -1.50M | |
| Income towards Parent CompanyParent Net Inc | -721.00 | -0.29M | -0.84M | -1.15M | -2.38M | -1.03M | -4.02M | -1.93M | -1.39M | -4.16M | -1.29M | -1.41M | -1.52M | -1.64M | -1.68M | -1.71M | -1.47M | -1.79M | -1.50M | |
| Net Income towards Common StockholdersNet Income | -721.00 | -0.29M | -0.84M | -1.15M | -2.38M | -1.03M | -4.02M | -1.93M | -1.39M | -4.16M | -1.29M | -1.41M | -1.52M | -1.64M | -1.68M | -1.71M | -1.47M | -1.79M | -1.50M | |
| Additional items | ||||||||||||||||||||
| EPS (Basic) | -0.04 | -0.13 | -0.18 | -0.77 | -0.11 | -0.39 | -0.16 | -0.11 | -0.20 | -0.06 | -0.06 | -0.06 | -0.97 | -0.97 | -0.98 | -0.84 | -0.63 | -0.51 | ||
| EPS (Diluted) | -0.07 | -0.16 | -0.17 | -0.77 | -0.11 | -0.39 | -0.16 | -0.11 | -0.20 | -0.06 | -0.06 | -0.06 | -0.97 | -0.97 | -0.98 | -0.84 | -0.63 | -0.51 | ||
| Shares Outstanding | 1.16M | 6.50M | 6.50M | 6.50M | 3.09M | 9.55M | 10.24M | 11.90M | 12.69M | 21.08M | 22.61M | 24.44M | 26.89M | 1.69M | 1.74M | 1.76M | 1.75M | 2.84M | 2.96M | |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 1.16M | 4.22M | 5.43M | 6.61M | 3.09M | 9.55M | 10.24M | 11.90M | 12.69M | 21.08M | 22.61M | 24.44M | 26.89M | 1.69M | 1.74M | 1.76M | 1.75M | 2.84M | 2.96M | |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 1.16M | 6.50M | 6.50M | 6.50M | 3.09M | 9.62M | 11.18M | 13.12M | 12.69M | 21.08M | 22.61M | 24.44M | 26.89M | 1.74M | 1.74M | 1.77M | 1.83M | 2.96M | 2.96M | |
| EBITDA | -0.22M | -0.78M | -1.15M | -2.37M | -1.70M | -2.55M | -1.40M | -1.48M | -4.13M | -1.23M | -1.36M | -1.43M | -1.51M | -1.62M | -1.66M | -1.37M | -1.69M | -1.40M | ||
| Interest ExpensesInt Expense | 5.02M | 1.05M | 0.57M | 0.10M | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
Pull Cardio Diagnostics Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CDIO&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CDIO", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CDIO&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();